PNC Form 4: Director Linda Medler Sells 71 Shares at $205.55
Linda R. Medler, a director of PNC Financial Services Group (PNC), reported insider transactions on Form 4.
Rhea-AI Filing Summary
Linda R. Medler, a director of PNC Financial Services Group (PNC), reported insider transactions on Form 4. The filing shows a sale of 71 shares of PNC common stock on 08/27/2025 at a price of $205.55 per share, and the amount of securities beneficially owned following the reported transaction is shown as 0 shares (direct ownership). The filing also includes an explanation that an aggregate of 11 shares were acquired by the reporting person through dividend reinvestment. The Form 4 is signed by an attorney-in-fact, Laura Gleason, dated 08/29/2025.
Positive
- Timely, specific disclosure of the sale date (08/27/2025), price ($205.55), and quantity (71 shares)
- Includes dividend reinvestment detail noting an aggregate of 11 shares acquired, improving transparency
- Filed and signed (attorney-in-fact Laura Gleason, dated 08/29/2025), indicating procedural compliance
Negative
- Reported direct beneficial ownership reduced to 0 shares after the sale, which could be noteworthy depending on prior holdings
- Form lacks context on prior total holdings or percentage ownership, limiting assessment of materiality
Insights
TL;DR: Director sold 71 PNC shares at $205.55, reporting zero beneficial ownership; transaction appears routine and disclosed under Section 16.
The Form 4 shows a straightforward sale of 71 shares by Linda R. Medler on 08/27/2025 at $205.55 per share with reported direct ownership of 0 shares after the sale. The filing also notes an aggregate acquisition of 11 shares via dividend reinvestment. From a market-impact perspective, the filing provides clear, timely disclosure of insider activity but does not include additional context such as percentage ownership or holdings pre-transaction, so materiality to valuation cannot be determined from this form alone.
TL;DR: The director’s sale is properly disclosed and executed by an attorney-in-fact; governance disclosure requirements appear satisfied.
The report identifies the reporting person as a director and uses the required Form 4 disclosure conventions, including transaction code and signature by an attorney-in-fact dated 08/29/2025. The notation about 11 shares acquired through dividend reinvestment clarifies additional share activity. The filing does not indicate any derivative transactions or plan-based trading elections on the face of the form. As presented, the disclosure meets Section 16 reporting mechanics but provides limited information to assess governance signals beyond the reported trade.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | $5 Par Common Stock | 71 | $205.55 | $15K |
Footnotes (1)
- F1. Includes an aggregate of 11 shares of PNC common stock acquired by the reporting person through dividend reinvestment.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did Linda R. Medler report on Form 4 for PNC?
What was Linda Medler's beneficial ownership after the reported transaction?
Did the Form 4 report any purchases or dividend activity for PNC (PNC)?
Who signed the Form 4 for Linda R. Medler?
Does the Form 4 show any derivative transactions or 10b5-1 plan indicators?
AI-generated analysis. How Rhea-AI works. Not financial advice.